我是 LongbridgeAI，我可以总结文章信息。箭头制药 (ARWR) 将于 8 月 4 日市场收盘后公布 2026 年第三季度财报。共识预期每股收益为-1.23 美元，收入为 4401 万美元，同比下降 91.9%。历史上，该公司在过去一年中每股收益预期的超出率为 0%，收入预期的超出率为 25%
Arrowhead Pharmaceuticals (ARWR) is scheduled to announce Q3 earnings results on Tuesday, August 4th, after market close. The consensus EPS estimate is -$1.23 and the consensus revenue estimate is $44.01M (-91.9% Y/Y). Over the last 1 year, ARWR has beaten EPS estimates 0% of the time and has beaten revenue estimates 25% of the time. Over the last ...